¼¼°èÀÇ µ¿¹° ÁøÁ¤Á¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : Åõ¿© °æ·Îº°, µ¿¹° À¯Çüº°, ¾à¹° Á¾·ùº°, ÃÖÁ¾ ¿ëµµº°, ¿ëµµº°, Áö¿ªº° Àü¸Á ¹× ¿¹Ãø(2024-2031³â)
Global Animal Sedative Market Size, Share & Trends Analysis Report By Route of Administration, By Animal Type, By Drug Class, By End Use, By Application, By Regional Outlook and Forecast, 2024 - 2031
»óǰÄÚµå : 1522020
¸®¼­Ä¡»ç : KBV Research
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 323 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,600 £Ü 5,208,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,320 £Ü 6,250,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,048 £Ü 8,750,000
PDF (Corporate User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è µ¿¹° ÁøÁ¤Á¦ ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 5.5%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2031³â±îÁö 4¾ï 8,910¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ ÇǺΰú, Ä¡°ú, Á¾¾çÇÐ, Á¤Çü¿Ü°ú µî ¼öÀÇÇÐÀÌ Àü¹®È­µÊ¿¡ µû¶ó ƯÁ¤ Áø·á°ú¸ñ¿¡ ¸Â´Â ÁøÁ¤Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÀ±ÞÀÇ·á, ÀÀ±Þ±¸Á¶, ÀçȰ µî ƯÁ¤ Àü¹® ºÐ¾ß¿¡ ÁßÁ¡À» µÐ Àü¹® ¼öÀÇÇÐ ¼¾ÅͰ¡ ¼³¸³µÊ¿¡ µû¶ó °íµµÀÇ ÁøÁ¤ ±â¼ú¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌó·³ ¼öÀÇÇÐ ¼­ºñ½ºÀÇ È®´ë°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ÁøÁ¤Á¦´Â µ¿¹°º´¿ø¿¡ ÀÖ¾î °í°¡ÀÇ Á¶´Þ ºñ¿ëÀ» ¼ö¹ÝÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¿©±â¿¡´Â ÁøÁ¤Á¦ÀÇ Ãʱ⠱¸¸Å ºñ¿ë°ú ¸¶Ãë Àåºñ, ¸ð´ÏÅ͸µ ±â±â, ÀÏȸ¿ë Àåºñ¿Í °ü·ÃµÈ Áö¼ÓÀûÀÎ ºñ¿ëÀÌ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ, ¼öÀÇ»ç´Â ÁøÁ¤Á¦ »ç¿ë°ú ±¸¼Ó ¶Ç´Â ¸¶ÃëÀÇ ´ëü ¹æ¹ýÀÇ ºñ¿ë È¿°ú¼ºÀ» ºñ±³ °ËÅäÇØ¾ß ÇÕ´Ï´Ù. µû¶ó¼­ ÁøÁ¤Á¦ÀÇ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¿î¼Û ¹× ¹°·ù Á¦ÇÑÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ ÁøÁ¤Á¦¸¦ Æ÷ÇÔÇÑ ÀǾàǰÀÇ °ø±Þ¸Á¿¡ È¥¶õÀÌ ¹ß»ýÇß½À´Ï´Ù. ¶ÇÇÑ, µ¿¹°º´¿ø°ú µ¿¹°º´¿øÀº ÆÒµ¥¹Í ±â°£ µ¿¾È ±ä±ÞÇϰí ÇʼöÀûÀÎ Áø·á ¼­ºñ½º¿¡ ÁßÁ¡À» µÎ¾ú°í, ÁøÁ¤Á¦°¡ ÇÊ¿äÇÏÁö ¾ÊÀº Ä¡·á¸¦ ¿ì¼±½ÃÇß½À´Ï´Ù. ÀÌó·³ COVID-19 ÆÒµ¥¹ÍÀº ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

Åõ¿© °æ·ÎÀÇ Àü¸Á

Åõ¿© °æ·Î¿¡ µû¶ó ½ÃÀåÀº ºñ°æ±¸¿ë°ú °æ±¸¿ëÀ¸·Î ³ª´¹´Ï´Ù. °æ±¸ ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 40%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. °æ±¸ Åõ¿©´Â ¹Ù´ÃÀ̳ª ÁÖ»ç±â°¡ ÇÊ¿äÇÏÁö ¾Ê½À´Ï´Ù. ÀÌ´Â µ¿¹°ÀÇ ½ºÆ®·¹½º¸¦ ÁÙÀ̰í ÁÖÀΰú ¼öÀǻ翡°Ô Æí¸®ÇÔÀ» Á¦°øÇÕ´Ï´Ù.

µ¿¹°Çü Àü¸Á

µ¿¹° À¯Çüº°·Î ½ÃÀåÀº °³, °í¾çÀÌ, ¸», ±âŸ·Î ³ª´¹´Ï´Ù. °í¾çÀÌ ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 25%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¹é½Å Á¢Á¾, °Ç°­ °ËÁø, °æ¹ÌÇÑ ½Ã¼úÀ» Æ÷ÇÔÇÑ Á¤±âÀûÀÎ ¼öÀÇ»ç Áø·á´Â Á¾Á¾ °í¾çÀÌ¿¡°Ô ÁøÁ¤Á¦¸¦ »ç¿ëÇØ¾ß ÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.

¾à¹°ÀÇ Á¾·ù¿¡ ´ëÇÑ Àü¸Á

¾à¹° Á¾·ùº°·Î ½ÃÀåÀº Æä³ëƼ¾ÆÁø, º¥Á¶µð¾ÆÁ¦ÇÉ, ¥á-2 ¾Æµå·¹³¯¸° ¼ö¿ëü ÀÛ¿ëÁ¦, ºÎƼ·ÎÆä³í, ±âŸ·Î ºÐ·ùµÇ¸ç, 2023³â¿¡´Â º¥Á¶µð¾ÆÁ¦ÇÉ ºÎ¹®ÀÌ ½ÃÀå¿¡¼­ 24%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. µð¾ÆÁ¦ÆÊ°ú ¹Ì´ÙÁ¹¶÷°ú °°Àº º¥Á¶µð¾ÆÁ¦ÇÉÀº µ¿¹°ÀÇ ½ºÆ®·¹½º¿Í ºÒ¾ÈÀ» ÁÙÀÌ´Â µ¥ ¸Å¿ì È¿°úÀûÀÔ´Ï´Ù. µû¶ó¼­ ¼öÀÇ»ç Áø·á, ¹Ì¿ë, ¿î¼Û ¹× ±âŸ ½ºÆ®·¹½º°¡ ¸¹Àº »óȲ¿¡¼­ µ¿¹°À» ÁøÁ¤½ÃŰ´Â µ¥ ¸Å¿ì À¯¿ëÇÕ´Ï´Ù.

ÃÖÁ¾ ¿ëµµ Àü¸Á

ÃÖÁ¾ ¿ëµµº°·Î ½ÃÀåÀº º´¿ø°ú Àü¹® ¼¾ÅÍ·Î ºÐ·ùµË´Ï´Ù. Àü¹® ¼¾ÅÍ ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 48%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇß½À´Ï´Ù. Àü¹® ¼¾ÅÍ´Â Á¾¾çÇÐ, ½Å°æÇÐ, ½ÉÀåÇÐ, ÇǺΰú, ÀÀ±Þ ÀÇ·á¿Í °°Àº ƯÁ¤ ºÐ¾ß¿¡¼­ Àü¹®ÀûÀÎ ¼öÀÇÇÐ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù.

¿ëµµ Àü¸Á

¿ëµµº°·Î ½ÃÀåÀº ¼ö¼ú¿ë, Áø´Ü¿ë, ±âŸ·Î ³ª´µ¸ç, 2023³â Áø´Ü ºÎ¹®Àº ½ÃÀå¿¡¼­ 36%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÁøÁ¤Á¦´Â Á¾Á¾ ¿¢½º·¹ÀÌ, ÃÊÀ½ÆÄ, CT ½ºÄµ, MRI¿Í °°Àº Áø´Ü ¿µ»ó °Ë»ç Áß¿¡ µ¿¹°À» ÁøÁ¤½ÃŰ°í ¿òÁ÷ÀÓÀ» ÁÙÀÔ´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«·Î ºÐ¼®µÇ¾ú½À´Ï´Ù. ºÏ¹Ì´Â 2023³â ½ÃÀå¿¡¼­ 38%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. ºÏ¹Ì´Â °³, °í¾çÀÌ ¹× ±âŸ ¹Ý·Áµ¿¹° Àα¸°¡ ¸¹¾Æ Àü ¼¼°è¿¡¼­ ¹Ý·Áµ¿¹° »çÀ°·üÀÌ °¡Àå ³ôÀº Áö¿ª Áß ÇϳªÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå ¿ä¶÷

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå ¼¼°èÀÇ µ¿¹° ÁøÁ¤Á¦ ½ÃÀå : Åõ¿© °æ·Îº°

Á¦5Àå ¼¼°èÀÇ µ¿¹° ÁøÁ¤Á¦ ½ÃÀå : µ¿¹° À¯Çüº°

Á¦6Àå ¼¼°èÀÇ µ¿¹° ÁøÁ¤Á¦ ½ÃÀå : ¾à¹° Á¾·ùº°

Á¦7Àå ¼¼°èÀÇ µ¿¹° ÁøÁ¤Á¦ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ µ¿¹° ÁøÁ¤Á¦ ½ÃÀå : ¿ëµµº°

Á¦9Àå ¼¼°èÀÇ µ¿¹° ÁøÁ¤Á¦ ½ÃÀå : Áö¿ªº°

Á¦10Àå ±â¾÷ °³¿ä

Á¦11Àå µ¿¹° ÁøÁ¤Á¦ ½ÃÀå ¼º°ø Çʼö Á¶°Ç

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Animal Sedative Market size is expected to reach $489.1 million by 2031, rising at a market growth of 5.5% CAGR during the forecast period.

The Asia Pacific region is seeing an expansion of veterinary clinics, hospitals, and specialty centers offering comprehensive healthcare services for animals. This expansion includes advanced diagnostic capabilities and surgical interventions, where sedatives are essential for safe and effective treatment. Consequently, the Asia Pacific region would acquire nearly 27% of the total market share by 2031.

There is a growing recognition of animals as sentient beings deserving of humane treatment. This perspective is driving demand for sedatives that minimize stress, anxiety, and pain during veterinary procedures, ensuring animals are treated with compassion and care. Similarly, pet owners and the general public are increasingly educated about animal welfare issues and expect high standards of care for their pets. Hence, a rising focus on animal welfare propels the market's growth.

Additionally, the growing specialization within veterinary medicine, such as dermatology, dentistry, oncology, and orthopedics, has led to a higher demand for sedatives tailored to specific medical procedures. In addition, the establishment of specialty veterinary centers focused on specific areas of expertise, such as emergency care, critical care, and rehabilitation, drives the need for advanced sedation techniques. Thus, the expansion of veterinary services is driving the market's growth.

However, Sedative products often involve high procurement costs for veterinary practices. This includes the initial purchase of sedative formulations and ongoing expenses related to anesthesia equipment, monitoring devices, and disposables. In addition, veterinarians must weigh the cost-effectiveness of using sedatives against alternative methods of restraint or anesthesia. Thus, the high cost of sedative products is hindering market growth.

Moreover, restrictions on transportation and logistics disrupted the supply chain for pharmaceutical products, including these sedatives. In addition, veterinary clinics and hospitals shifted their focus to emergency and essential care services during the pandemic, prioritizing treatments that did not require sedation unless necessary. Thus, the COVID-19 pandemic had a negative impact on the market.

Route of Administration Outlook

By route of administration, the market is divided into parenteral and oral. The oral segment procured 40% revenue share in the market in 2023. Oral administration does not require needles or syringes. This can be less stressful for animals and more convenient for owners and veterinary staff.

Animal Type Outlook

Based on animal type, the market is divided into dogs, cats, horses, and others. The cats segment attained 25% revenue share in the market in 2023. Regular veterinary visits, including vaccinations, check-ups, and minor procedures, often necessitate using sedatives for cats.

Drug Class Outlook

On the basis of drug class, the market is segmented into phenothiazines, benzodiazepines, alpha-2 adrenergic receptor agonists, butyrophenones, and others. In 2023, the benzodiazepines segment attained 24% revenue share in the market. Benzodiazepines, such as diazepam and midazolam, are highly effective in reducing stress and anxiety in animals. This makes them invaluable for calming animals during veterinary visits, grooming, transportation, and other potentially stressful situations.

End Use Outlook

Based on end use, the market is categorized into hospitals and specialty centers. The specialty centers segment witnessed 48% growth rate in the market in 2023. Specialty centers provide specialized veterinary care in specific areas such as oncology, neurology, cardiology, dermatology, and emergency critical care.

Application Outlook

Based on application, the market is divided into surgical, diagnostic, and others. In 2023, the diagnostic segment procured 36% revenue share in the market. Sedatives often calm animals and reduce movement during diagnostic imaging procedures such as X-rays, ultrasounds, CT scans, and MRIs.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 38% revenue share in the market in 2023. North America has one of the highest rates of pet ownership globally, with a large population of dogs, cats, and other companion animals.

List of Key Companies Profiled

Global Animal Sedative Market Report Segmentation

By Route of Administration

By Animal Type

By Drug Class

By End Use

By Application

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Animal Sedative Market by Route of Administration

Chapter 5. Global Animal Sedative Market by Animal Type

Chapter 6. Global Animal Sedative Market by Drug Class

Chapter 7. Global Animal Sedative Market by End Use

Chapter 8. Global Animal Sedative Market by Application

Chapter 9. Global Animal Sedative Market by Region

Chapter 10. Company Profiles

Chapter 11. Winning Imperatives of Animal Sedative Market

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â